Orthofix (OFIX) awards new options and RSUs to CP&BOO Lucas Vitale

Rhea-AI Filing Summary

Orthofix Medical Inc. reported that executive Lucas Vitale, its CP&BOO, acquired new equity awards. On March 3, 2026, he received 45,546 employee stock options and a separate grant of 19,186 shares of common stock in the form of restricted stock units.

The restricted stock units vest in three equal installments, with one-third of the shares vesting on each of the first, second, and third anniversaries of the grant date. Following these grants, Vitale directly holds 167,030 shares of common stock, including previously reported restricted stock units and shares acquired under Orthofix’s Stock Purchase Plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Vitale Lucas

Role CP&BOO

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	45,546	$0.00	--
Grant/Award	Common Stock	19,186	$0.00	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 45,546 shares (Direct); Common Stock — 167,030 shares (Direct)

Footnotes (1)

1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date. Includes 123,894 previously reported restricted stock units and an aggregate of 12,527 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2025 and 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b). The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vitale Lucas

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TX 75056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CP&BOO

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		19,186(1)	A	$0	167,030(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$13.03	03/03/2026		A		45,546		(3)	03/03/2033	Common Stock	45,546	$0	45,546	D

Explanation of Responses:

1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.

2. Includes 123,894 previously reported restricted stock units and an aggregate of 12,527 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2025 and 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

3. The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

	/s/ J. Andres Cedron, Attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Orthofix (OFIX) grant to Lucas Vitale?

Orthofix granted Lucas Vitale 45,546 employee stock options and 19,186 shares of common stock as restricted stock units. These awards were approved by the board’s Compensation and Talent Development Committee as part of his executive compensation package.

How do Lucas Vitale’s new restricted stock units at Orthofix (OFIX) vest?

The restricted stock units vest in three equal parts, with one-third of the covered shares vesting on each of the first, second, and third anniversaries of the grant date. This creates a multi‑year incentive for continued service at Orthofix.

What is Lucas Vitale’s Orthofix (OFIX) common stock ownership after these awards?

After the March 3, 2026 grants, Lucas Vitale directly owns 167,030 shares of Orthofix common stock. This total includes previously reported restricted stock units and 12,527 shares acquired under Orthofix’s Stock Purchase Plan in 2025.

What role does the Compensation and Talent Development Committee play at Orthofix (OFIX)?

Orthofix’s Compensation and Talent Development Committee administers the plan under which Lucas Vitale’s restricted stock units were granted. It approves equity awards to executives and sets vesting terms, aligning compensation with company objectives and long‑term performance incentives.

What is Orthofix’s Stock Purchase Plan (SPP) mentioned in the Form 4 for OFIX?

Orthofix’s Stock Purchase Plan is described as a “Stock Purchase Plan” under Rule 16b‑3(b)(5). Shares acquired under the SPP, including 12,527 shares held by Lucas Vitale, are exempt from Section 16(b) short‑swing profit rules, providing a compliant way for ongoing share accumulation.